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Abstract: The effective and non-invasive diagnosis of skin cancer is a hot topic, since biopsy 
is a costly and time-consuming surgical procedure. As skin relief is an important biophysical 
feature that can be difficult to perceive with the naked eye and by touch, we developed a 
novel 3D imaging scanner based on fringe projection to obtain morphological parameters of 
skin lesions related to perimeter, area and volume with micrometric precision. We measured 
608 samples and significant morphological differences were found between melanomas and 
nevi (p<0.001). The capacity of the 3D scanner to distinguish these lesions was supported by 
a supervised machine learning algorithm resulting in 80.0% sensitivity and 76.7% specificity. 
© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction 
The incidence of skin cancer increases every year, thus it is crucial to diagnose and treat it 
effectively. Risk factors are too much exposure to sunlight, fair skin, family history and age. 
The World Health Organization estimates that 60,000 people die every year from skin cancer: 
48,000 from melanoma, its most aggressive form, and 12,000 from other types [1]. 
Skin cancer is usually diagnosed through visual inspection followed by dermoscopy. In 
order to facilitate dermoscopic diagnosis and to spotlight the warning signs of the most 
common type of melanoma, the ????? criteria were proposed: ? is for asymmetry, ? for 
border irregularity, ? for color, D for diameter and ? for evolution [2]. However, these 
methods result in a significant number of false positives. Currently, the gold standard for 
diagnosis is histopathology, which requires the surgical excision of the tumor (biopsy), is 
time consuming, uncomfortable for patients and contributes to the high direct annual costs for 
the diagnosis and treatment of skin cancer [3]. Due to the large number of affected people, 
much research has focused on reducing unnecessary biopsies. Some authors have tried to 
detect skin cancer quantitatively and non-invasively through optical devices. Confocal 
microcopy [4], optical coherence tomography [5] and multispectral imaging [6,7] are among 
the most commonly used imaging modalities. Three-dimensional (3D) technology can also be 
used to retrieve topographic information of cutaneous lesions, producing a height map of the 
lesion’s surface from which parameters of area, volume and texture can be calculated. 3D 
techniques can be mechanical and optical, but they are mainly classified into two categories: 
ex-vivo techniques, which measure skin indirectly from a replica; and in-vivo techniques [8]. 
Ex-vivo techniques are reliable and provide high resolutions, but since they are based on 
point-wise scanning they are too slow to be performed in clinical environments. In-vivo 
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Finally, the corresponding phases between both cameras are identified and the height map can 
be reconstructed by means of the triangulation principle [8]. Additionally, the RGB 
information obtained with the color camera is superimposed to the geometric coordinates of 
the object points (X, Y, Z). The calibration of the three cameras followed the technique 
proposed by Tsai [15]. The 3D scanner developed in this study offers a spatial resolution of 
15 μm (XY dimension) and an acquisition time less than 4.5 s per whole FOV. 
Clinical measurements were carried out at the Hospital Clínic i Provincial de Barcelona 
(Spain) and the Università degli Studi di Modena e Reggio Emilia (Italy). A total of 654 skin 
lesions from Caucasian individuals were assessed. Patients remained still to avoid motion 
artifacts; the area over the skin was cleaned and hair was carefully cut instead of shaved to 
avoid irritation. All patients provided written informed consent before any examination and 
ethical committee approval was obtained. The study complied with the tenets of the 1975 
Declaration of Helsinki (Tokyo revision, 2004). The lesions were diagnosed by 
dermatologists using a commercial dermoscope and the confocal microscope VivaScope 1500 
from MAVIG GmbH. When malignancy was suspected, a histological analysis was carried 
out. From the total set of lesions, 93% (608) could be measured with the 3D prototype; in the 
remaining 7% (46), the use of the 3D scanner was impractical for the body area involved. Out 
of the 608 lesions measured, 194 (32%) could be analyzed. The remaining 414 (68%) were 
rejected because of artifacts caused by micro-movements, lesions out of the system’s FOV, 
and hair inaccurately removed. Regarding the lesions properly collected, 81 (42%) were 
benign nevi; 60 (31%) melanomas; 18 (9%) basal cell carcinomas; 18 (9%) non-nevi benign 
lesions such as angiomas, dermatofibromas and actinic keratosis; 11 (6%) seborrheic 
keratosis; and 6 (3%) squamous cell carcinomas. 
2.2 3D image processing 
Point-wise height maps of each lesion were obtained through the reconstruction of the fringe 
images. Next, the 3D reconstructed data was imported into the software MountainsMap (Fig. 
2). Preliminary removal of artifacts was carried out. A first operator levelled the scanned 
surface to remove the general slope caused by small tilts. A second operator zoomed in the 
area where the lesion and the surrounding healthy skin were located to select the Region of 
Interest (ROI). Finally, the application of a Fast Fourier Transform (FFT) filter allowed the 
exclusion of frequencies corresponding to artifacts of movement. Lesions were segmented 
from the healthy skin on the color image and the selected contour was pasted into the 3D 
image to extract the rest of parameters. Their perimeter was obtained by manual 
segmentation. Next, the area and volume were calculated by means of an operator that 
accounts for both peaks (convex curvatures) and holes (concave curvatures). The area and 
volume divided by the perimeter (Ap in mm and Vp in mm2) were also computed to determine 
which lesions, despite presenting a smaller perimeter, had a greater surface or volume. In 
order to compute additional parameters, the 3D surface was converted into a series of 2D 
profiles (horizontal and vertical axial cuts). A set of 200 horizontal profiles and their mean 
profile were obtained. From them, parameters for roughness and texture established by the 
ISO 25178 were calculated such as the profile maximum height, skewness and arithmetic 
mean deviation, number of peaks per centimeter and amplitude of the peaks. 
2.3 Statistical analysis and classification algorithm 
The parameters described were compared among types of lesions to evaluate their differences 
using SPSS statistics V23.0 (IBM Corp.). Comparisons were considered statistically 
significant for p-values under 0.05. Non-nevi benign lesions, seborrheic keratosis and 
squamous cell carcinomas were excluded from the statistical analysis due to the low number 
of samples. The Kolmogorov-Smirnov test was used to evaluate the normal distribution of all 
variables. The ANOVA / Kruskal-Wallis (KW) tests were used to compare the data among 
groups of skin lesions for parametric and non-parametric variables, respectively. The T-test / 
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Mann-Whitney U (MWU) tests were used to compare outcome measures between pairs of 
groups for normal and non-normal distributed data. 
In order to classify the lesions, the accuracy of the parameters to train a good 
classification model was evaluated. For this purpose, the Matlab R2015a Classification 
Learner application was used to perform supervised machine learning by supplying the 3D 
morphological parameters with statistical significance and the known classification of the 
lesions. Since only 18 basal cell carcinomas were measured, they were excluded from this 
process to avoid inaccurate results from the statistical analysis and machine learning 
algorithms. The Classification Learner uses the data to train different models. Accordingly, an 
automated training was performed to search for the best classification model including 
discriminant analysis, decision trees, support vector machines and nearest neighbors. The 
different validation options of the fitted models were analyzed beforehand [16]. The first 
scheme was the ‘Cross Validation’, in which the data is divided into k subfolds, a model is 
trained using the out-of-fold observations, and then, the algorithm calculates the average test 
error for all folds. For this, k was set equal to two and the samples in the two folds were 
randomly selected by the algorithm. The second scheme used was the ‘Holdout Validation’, 
which divides the data into two folds, containing random observations of each lesion, and 
uses one fold for training and the second for validating. The percentage of data used for 
training and validating was set equally to 50%. Additionally, in order to test an algorithm that 
does not divide the data into training and validation sets, the ‘No-Validation’ scheme, in 
which all data is used for training and afterwards also for validating, was also tested. 
 
Fig. 2. 3D data of (a) a nevus and (b) a melanoma. Top, from left to right: height maps and 3D 
views of the surface after image processing (leveling, zooming, filling-in non-measured points 
and FFT filtering). The mean profile of each lesion is shown at the bottom. 
3. Results 
For nevi (N), melanomas (MM) and basal cell carcinomas (BCC), all analyzed parameters 
followed a non-normal distribution (p < 0.05). Of all parameters computed, the KW test 
reported significant differences for the different types of lesions regarding area, A, volume, V, 
perimeter, P, normalized area, Ap, and volume, Vp (p < 0.001). In contrast, the profile and 
amplitude parameters calculated following the ISO 25178 did not provide significant 
differences (p > 0.05), and for this reason they are not reported. Table 1 shows the mean ( ± 
standard deviation) and the minimum and maximum values (in parenthesis) for each type of 
lesion and globally (Total). In addition, the MWU test analyzed if significant differences 
existed between pairs of types of lesions. As shown in Table 2, when comparing MM versus 
N, all parameters showed significant differences (p < 0.001), meaning that MM and N are 
significantly different. In contrast, when comparing MM vs BCC and N vs BCC, differences 
were not significant, with the exception of the area when comparing BCC with MM (p = 
0.034), indicating the complexity of discriminating BCC from MM and N. 
Regarding the machine learning based classification algorithm, the best results were 
obtained with decision trees (e.g. Bagged Trees) and nearest neighbors (e.g. Weighted k-
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Nearest Neighbor, KNN). The final data set contained 60 observations of nevi and 60 of 
melanomas. The nevi observations were randomly chosen from the 81 to avoid returning 
higher specificities than sensitivities as a result of the higher number of nevi. Table 3 contains 
the different validation schemes and the classification models that provided the lowest error 
rate. The predictive accuracy of each classification model is shown in terms of sensitivity and 
specificity, i.e., the percentage of melanomas and the percentage of nevi correctly identified. 
The sensitivity and specificity corresponding to the ‘No Validation’ scheme were 100%, with 
an associate error rate of 0% for all trials. The repeatability of the results was also assessed by 
the creation of different random sets of nevi. The ‘Cross Validation’ scheme applied to the 
different sets of nevi led to maximum variations of 5.00% for sensitivity and specificity and 
0.05% of error rate. Regarding the ‘Holdout Validation’, the variations of sensitivity, 
specificity and error rate were 10.00%, 13.40% and 11.65%, respectively. 
Table 1. 3D Morphological Parameters with Statistically Significant Differences among 
Groups (p < 0.001, KW Test): area (A, mm2), volume (V, mm3), perimeter (P, mm), Ap 
(mm) and Vp (mm2). 
 N MM BCC Total 
A 28.6 ± 23.9 (2.9, 127.3) 50.8 ± 38.4 (4.9, 128.8) 30.0 ± 18.0 (8.2, 64.8) 37.2 ± 31.5 (2.9, 182.8) 
V 5.8 ± 7.9 (0.2, 37.6) 15.9 ± 39.6 (0.5, 298.2) 7.5 ± 7.4 (0.5, 0.2) 9.8 ± 25.5 (0.2, 298.2) 
P 18.9 ± 7.7 (6.6, 44.4) 26.5 ± 10.9 (7.9, 53.3) 20.9 ± 6.5 (13.5, 35.1) 21.9 ± 9.6 (6.6, 53.3) 
Ap 1.4 ± 0.8 (0.5, 7.1) 1.7 ± 0.6 (0.6, 3.5) 1.4 ± 0.5 (0.5, 2.5) 1.5 ± 0.7 (0.5, 7.1) 
Vp 0.19 ± 0.20 (0.02, 1.42) 0.5 ± 1.9 (0.04, 14.6) 0.29 ± 0.28 (0.31, 1.24) 0.3 ± 1.7 (0.02, 14.63) 
Table 2. p-values between Groups of Lesions (MWU Test) 
 A V P Ap Vp 
MM vs N < 0.001* < 0.001* < 0.001* < 0.001* < 0.001* 
MM vs BCC 0.034* 0.270 0.052 0.075 0.943 
N vs BCC 0.341 0.150 0.160 0.835 0.085 
*Statistically significant differences. 
Table 3. Sensitivity (SN), Specificity (SP) and Error Rate (ER) Values for the ‘Cross’ and 
‘Holdout Validation’ Approaches. 
Validation Scheme Classification Model SN (%) SP (%) ER (%) 
Cross Validation Bagged Trees 70.00 68.30 30.85 
Holdout Validation Weighted KNN 80.00 76.70 21.65 
4. Discussion 
High accuracy (80.00% sensitivity and 76.70% specificity) was obtained through the 
‘Holdout Validation’ scheme and training a ‘Weighted KNN’ classification model. This 
model categorizes query points based on their distance to the nearest k neighbors in a training 
data set. Specifically, medium distinction between classes is set with a number of k neighbors 
equal to ten, using a distance weight. On the other hand, the ‘No Validation’ scheme returned 
100% sensitivity and specificity values since the data set was classified with respect to the 
data set itself. In conclusion, ‘Holdout Validation’ achieved the best results, but ‘Cross 
Validation’ was considered the most reliable approach, since it uses both sets for training and 
validation. Other methods such as multispectral imaging systems, which acquire images at 
different wavelengths, have also been used to detect skin cancer. Comparing the 3D results 
with those obtained in a previous study where a multispectral imaging system from 414 nm to 
995 nm was applied to the study of skin cancer [6], our results show significantly increased 
specificity at the only expense of a slightly lower sensitivity. The authors obtained sensitivity 
and specificity of 87.2% and 54.5%, respectively, for a 50%-50% validation scheme with a 
customized classification algorithm in a set of 502 lesions (nevi, melanomas and basal cell 
carcinomas). Another study evaluated skin lesions combining this system with another that 
used 995 nm to 1613 nm wavelengths [7]. The sensitivity and specificity obtained were 
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85.7% and 76.9%, respectively, for a no-validation algorithm when analyzing 14 melanomas 
and 39 nevi. We should underscore that the classification algorithms and the sample sets used 
were not the same for all studies. 
5. Conclusions 
This is the first report showing that non-invasive 3D technology based on fringe projection 
could assist practitioners in making a final diagnosis and contribute to a significant reduction 
in the number of false positives thanks to its enhanced specificity. Further work will focus on 
reducing the system sensitivity to the micro-movements of the patients, since the main cause 
for discarding 3D images was the inability to adequately filter all image artifacts. 
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